Patrik Jeanmonod - Jul 22, 2021 Form 3 Insider Report for Cytek BioSciences, Inc. (CTKB)

Role
Chief Financial Officer
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Patrik Jeanmonod
Stock symbol
CTKB
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
3
Date filed
7/22/2021, 09:08 PM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTKB Common Stock 96K Jul 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTKB Stock Option (Right to Buy) Jul 22, 2021 Common Stock 243K $0.40 Direct F1
holding CTKB Stock Option (Right to Buy) Jul 22, 2021 Common Stock 38.7K $0.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on October 15, 2019; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.
F2 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 24, 2021; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.

Remarks:

Exhibit 24 - Power of Attorney